Our findings demonstrate that the combination of cryoablation with GM-CSF significantly suppressed tumor growth and enhanced immune response by elevating activated DC counts, aligning with the synergistic effect observed in murine glioma models where GM-CSF was found to enhance the immune function of splenic DCs (26). The gene discussed is CSF2; the disease is central nervous system cancer.